RGEN
Repligen Corporation
181.70$
+2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.6% | +0.6% | +0.4% | -1.1% | 0.0% | +0.8% | +1.7% | +0.8% | +0.9% | -0.6% | +0.7% | |
| – | +13.6% | +2.0% | +2.3% | -2.4% | -5.8% | -3.1% | +2.4% | +3.7% | +3.7% | +2.1% | +3.4% | |
| – | +19.1% | +3.9% | +3.7% | -3.1% | -3.4% | -7.9% | +1.7% | +5.6% | -24.4% | +2.9% | +4.1% | |
| – | +19.1% | +3.9% | +3.7% | -3.1% | -3.4% | -7.9% | +1.7% | +5.6% | +2.5% | +2.2% | +3.3% | |
| – | +17.0% | -6.8% | +6.5% | +4.7% | +3.9% | +9.9% | +6.5% | -5.1% | +6.5% | -4.4% | +4.1% | |
| – | -4.3% | -2.1% | -3.8% | -4.2% | -21.6% | +7.1% | +1.8% | +2.9% | +6.3% | +5.2% | +4.1% | |
| – | +13.6% | -0.1% | 0.0% | +0.2% | +4.4% | +5.0% | +2.9% | -0.1% | +0.2% | -0.7% | -0.2% | |
| – | +18.4% | -4.6% | -2.1% | +0.2% | +4.5% | +2.8% | -0.7% | -2.7% | -2.4% | -4.7% | -2.9% | |
| – | +64.8% | +1.4% | -0.4% | -7.0% | +5.3% | +1.1% | -3.1% | +0.1% | +0.4% | -2.2% | +1.6% | |
| – | -54.6% | +8.1% | -2.2% | -37.8% | +17.0% | +19.9% | -19.1% | +6.6% | +3.6% | -7.1% | +5.1% | |
| – | -74.0% | +5.6% | +3.0% | -85.1% | +24.1% | +0.3% | +5.9% | +20.4% | +11.6% | -2.3% | -8.3% | |
| – | +3.2% | -4.3% | +11.6% | +2.1% | +50.5% | -16.2% | -4.9% | +14.8% | +2.0% | +15.5% | -4.1% | |
| – | – | +0.7% | +0.7% | +0.7% | +0.8% | +0.8% | +0.8% | +0.8% | +0.8% | +0.8% | +0.8% | |
| – | -1.2% | +0.3% | +0.8% | +1.5% | -2.2% | +0.6% | +3.8% | +1.0% | +1.1% | 0.0% | +0.3% | |
| – | -6.8% | +1.9% | +0.8% | -0.7% | -7.7% | +1.4% | +3.6% | +3.5% | +3.0% | +1.8% | +1.1% | |
| – | -2.0% | +1.3% | -0.2% | +0.9% | -1.6% | +0.9% | -0.1% | +0.0% | +0.0% | +0.3% | 0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.